Masami Okabe

Title: Masami Okabe: Innovator in Therapeutic Bacteriology

Introduction

Masami Okabe is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of bacteriology, particularly in developing therapeutic applications for anaerobic enterobacteria. His innovative work aims to enhance treatment options for solid tumors and ischemic diseases.

Latest Patents

Masami Okabe holds 1 patent for a co-expression plasmid. The objective of this invention is to provide an anaerobic enterobacterium that exhibits a higher therapeutic effect on anaerobic sites, such as solid tumor tissues and ischemic disease sites. The bacterium is transformed with a plasmid that co-expresses two types of heterologous polypeptides. This plasmid comprises two secretory expression cassettes, each containing a promoter DNA, a DNA encoding a secretory signal peptide, a DNA encoding a heterologous polypeptide, and a terminator DNA. This innovative approach allows for the efficient secretion of two types of antibodies with anticancer effects outside the bacterial cell.

Career Highlights

Throughout his career, Masami Okabe has worked with notable companies in the biotechnology sector, including Anaeropharma Science, Inc. and Azusapharma Sciences, Inc. His work has significantly impacted the development of therapeutic solutions using engineered bacteria.

Collaborations

Masami Okabe has collaborated with esteemed colleagues, including Koichi Koseki and Koichiro Shioya. These partnerships have fostered advancements in his research and contributed to the success of his innovative projects.

Conclusion

Masami Okabe's contributions to the field of bacteriology and his innovative patent for a co-expression plasmid highlight his commitment to advancing therapeutic options for challenging medical conditions. His work continues to inspire future research in the field.